These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28387887)

  • 1. The renin-angiotensin system blockers as adjunctive therapy for cancer: a meta-analysis of survival outcome.
    Li XY; Sun JF; Hu SQ
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1375-1383. PubMed ID: 28387887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The renin-angiotensin system blockers and survival in digestive system malignancies: A systematic review and meta-analysis.
    Zhou Q; Chen DS; Xin L; Zhou LQ; Zhang HT; Liu L; Yuan YW; Li SH
    Medicine (Baltimore); 2020 Feb; 99(7):e19075. PubMed ID: 32049809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin receptor blockers are associated with lower mortality than ACE inhibitors in predialytic stage 5 chronic kidney disease: A nationwide study of therapy with renin-angiotensin system blockade.
    Lin CC; Wu YT; Yang WC; Tsai MJ; Liu JS; Yang CY; Li SY; Ou SM; Tarng DC; Hsu CC
    PLoS One; 2017; 12(12):e0189126. PubMed ID: 29216260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
    Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
    JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Renin-Angiotensin System Blockers on Mortality in Veterans Undergoing Cardiac Surgery.
    Antoniak DT; Walters RW; Alla VM
    J Am Heart Assoc; 2021 May; 10(10):e019731. PubMed ID: 33969701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with abdominal aortic aneurysms: nation-wide cohort study.
    Kristensen KE; Torp-Pedersen C; Gislason GH; Egfjord M; Rasmussen HB; Hansen PR
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):733-40. PubMed ID: 25633315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
    Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
    Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma.
    Chen YH; Huang CH; Lu HI; Chen CH; Huang WT; Hsieh MJ; Rau KM; Chang AY; Lin WC; Li SH
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1185-92. PubMed ID: 24961505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin-angiotensin system inhibitors prevent the recurrence of atrial fibrillation: a meta-analysis of randomized controlled trials.
    Han M; Zhang Y; Sun S; Wang Z; Wang J; Xie X; Gao M; Yin X; Hou Y
    J Cardiovasc Pharmacol; 2013 Oct; 62(4):405-15. PubMed ID: 23921300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis.
    Song T; Choi CH; Kim MK; Kim ML; Yun BS; Seong SJ
    Eur J Cancer Prev; 2017 Jan; 26(1):78-85. PubMed ID: 27158979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Renin-Angiotensin System Blockers in Acute Myocardial Infarction Patients with Acute Kidney Injury.
    Kim KA; Lee JE; Choi IJ; Lee KY; Kim CJ; Park MW; Park CS; Kim HY; Yoo KD; Jeon DS; Jeong MH; Chang K
    Cardiorenal Med; 2024; 14(1):178-190. PubMed ID: 38471483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effect of renin-angiotensin-aldosterone system blockade in patients with predialysis advanced chronic kidney disease, hypertension, and anemia.
    Hsu TW; Liu JS; Hung SC; Kuo KL; Chang YK; Chen YC; Hsu CC; Tarng DC
    JAMA Intern Med; 2014 Mar; 174(3):347-54. PubMed ID: 24343093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
    Opelz G; Döhler B
    Transplantation; 2014 Feb; 97(3):310-5. PubMed ID: 24492421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against death and renal failure by renin-angiotensin system blockers in patients with diabetes and kidney disease.
    Shen J; Huang YM; Song XN; Hong XZ; Wang M; Ling W; Zhang XX; Zhao HL
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27377659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.